GlassScriptPhysician profile
Diana C Kang
NPI 1053577478
$4,060.57
in general payments reported to CMS, 2019-2025
27 companies · $420 in 2025
The $420 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Urology) provider received nationally (typical 2025 total: $782).
See the full distribution for Urogynecology and Reconstructive Pelvic Surgery (Urology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $828 · 2020: $348 · 2021: $373 · 2022: $595 · 2023: $720 · 2024: $776 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,504 · Travel and Lodging: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,504.43 |
| Travel and Lodging | $411.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $724.00 | 2019-2025 | |
| Allergan, INC. | $516.71 | 2019-2021 | |
| Medtronic, INC. | $494.79 | 2022-2024 | Interstim |
| Valencia Technologies Corporation | $452.24 | 2023 | Ecoin Device Kit |
| Medtronic USA, INC. | $399.22 | 2019-2020 | |
| Astellas Pharma US INC | $223.79 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $192.08 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $187.60 | 2019-2025 | Erleada |
| Coloplast Corp | $109.52 | 2021-2023 | Speedicath |
| Urovant Sciences INC | $92.29 | 2022 | |
| Immunitybio, INC. | $71.78 | 2024-2025 | |
| Axonics, INC. | $67.55 | 2020-2023 | Axonics |
| Pfizer INC. | $57.32 | 2019-2024 | |
| Ferring Pharmaceuticals INC. | $50.40 | 2019-2025 | Adstiladrin |
| Accord Healthcare, INC. | $48.69 | 2023-2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $43.47 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $40.20 | 2020-2023 | Bard Urinary Drainage Bag |
| Endo Pharmaceuticals INC. | $40.15 | 2022 | |
| Teleflex LLC | $39.64 | 2021-2022 | |
| Histosonics, INC. | $37.13 | 2025 | |
| Rochester Medical Corporation | $30.48 | 2022 | |
| Applied Medical Resources Corporation | $28.96 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.70 | 2024 | Alunbrig |
| Convatec INC. | $23.54 | 2023 | |
| Urogen Pharma, INC. | $23.23 | 2025 | |
| Boston Scientific Corporation | $19.28 | 2019 | |
| Dendreon Pharmaceuticals LLC | $18.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Kang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.